{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T10:05:58Z","timestamp":1766052358885,"version":"3.48.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the superior success rate of lateral internal sphincterotomy for managing chronic anal fissure (CAF), there is a trend towards sphincter-preserving treatment due to the increased risk of incontinence. Botulinum toxin (BT) and fissurectomy are two sphincter-preserving options for CAF. We aim to assess if combining fissurectomy with botox treatment is superior to botulinum toxin alone in the management of CAF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study was conducted across two Sydney hospitals over 7\u00a0years. All patients with a CAF managed with either BT and fissurectomy (group\u00a01) or BT only (group\u00a02) were included. Primary outcome was healing rate defined as resolution or significant improvement of perianal symptoms at initial follow-up. Secondary outcomes were persistence, recurrence, re-intervention and faecal incontinence rate. Follow-up questionnaire was conducted to compare long-term outcomes between the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty-seven patients met the inclusion criteria (group\u00a01, 37; group\u00a02, 20). Mean BT dose and injection location between the groups were similar (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.259 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.427). There was a 65% response rate to the follow-up questionnaire. Median follow-up was 34.3\u00a0months (range 0.4\u201393). There was no difference in healing (56.7% vs. 50%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.561), recurrence (37.8% vs. 30%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.383) or re-intervention rate (13.5% vs. 20%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.888). Long-term incontinence rate was significantly higher in patients group\u00a02 (0% vs. 10%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.010), with two patients reporting persistent flatus incontinence. Median overall satisfaction score was 3\/4 (range 1\u20134), in both groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.469).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Botulinum toxin with or without fissurectomy is a safe sphincter-sparing treatment option for CAF. However, the addition of fissurectomy to BT does not improve healing rates and we therefore recommend BT injection alone as a second-line treatment of CAF in patients who fail topical treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10151-025-03153-z","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T07:17:50Z","timestamp":1747898270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of chronic anal fissures: should fissurectomy be performed with botulinum toxin injection?"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6731-6101","authenticated-orcid":false,"given":"R.","family":"Quinn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ellis-Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Albayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"3153_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-14-129","author":"D Mapel","year":"2014","unstructured":"Mapel D, Schum M, Von Worley A (2014) The epidemiology and treatment of anal fissures in a population-based cohort. BMC Gastroenterol. https:\/\/doi.org\/10.1186\/1471-230X-14-129","journal-title":"BMC Gastroenterol"},{"key":"3153_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/DCR.0000000000002664","volume":"66","author":"JS Davids","year":"2023","unstructured":"Davids JS, Hawkins AT, Bhama AR et al (2023) The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of anal fissures. Dis Colon Rectum 66:190\u2013199","journal-title":"Dis Colon Rectum"},{"key":"3153_CR3","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00384-020-03699-4","volume":"35","author":"PA Boland","year":"2020","unstructured":"Boland PA, Kelly ME, Donlon NE et al (2020) Management options for chronic anal fissure: a systematic review of randomised controlled trials. Int J Colorectal Dis 35:1807\u20131815","journal-title":"Int J Colorectal Dis"},{"key":"3153_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12893-023-02223-z","volume":"23","author":"A Brillantino","year":"2023","unstructured":"Brillantino A, Renzi A, Talento P et al (2023) The Italian Unitary Society of Colon-Proctology (SIUCP: Societa Italiana Unitaria di Colonproctologia) guidelines for the management of anal fissure. BMC Surg 23:311","journal-title":"BMC Surg"},{"key":"3153_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.surg.2021.11.030","volume":"172","author":"JZ Jin","year":"2022","unstructured":"Jin JZ, Bhat S, Park B et al (2022) A systematic review and network meta-analysis comparing treatments for anal fissure. Surgery 172:41\u201352","journal-title":"Surgery"},{"key":"3153_CR6","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1007\/s00268-016-3693-9","volume":"40","author":"A Bobkiewicz","year":"2016","unstructured":"Bobkiewicz A, Francuzik W, Krokowicz L et al (2016) Botulinum toxin injection for treatment of chronic anal fissure: is there any dose-dependent efficiency? A meta-analysis. World J Surg 40:3064\u20133072","journal-title":"World J Surg"},{"key":"3153_CR7","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1111\/codi.16762","volume":"25","author":"KLR Cross","year":"2023","unstructured":"Cross KLR, Brown SR, Kleijnen J et al (2023) The Association of Coloproctology of Great Britain and Ireland guideline on the management of anal fissure. Colorectal Dis 25:2423\u20132457","journal-title":"Colorectal Dis"},{"key":"3153_CR8","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10151-017-1664-2","volume":"21","author":"RL Nelson","year":"2017","unstructured":"Nelson RL, Manuel D, Gumienny C et al (2017) A systematic review and meta-analysis of the treatment of anal fissure. Tech Coloproctol 21:605\u2013625","journal-title":"Tech Coloproctol"},{"key":"3153_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00053-020-00454-9","volume":"42","author":"M Holzgang","year":"2020","unstructured":"Holzgang M, Jayne D (2020) Lateral internal sphincterotomy (LIS)\u2014still top gun in chronic anal fissure treatment? Coloproctology 42:478\u201384","journal-title":"Coloproctology"},{"key":"3153_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10151-014-1121-4","volume":"18","author":"HL Chen","year":"2014","unstructured":"Chen HL, Woo XB, Wang HS et al (2014) Botulinum toxin injection versus lateral internal sphincterotomy for chronic anal fissure: a meta-analysis of randomized control trials. Tech Coloproctol 18:693\u2013698","journal-title":"Tech Coloproctol"},{"key":"3153_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.23736\/S2724-5691.24.10228-6","volume":"79","author":"S Ascanelli","year":"2024","unstructured":"Ascanelli S, Rossin E, Aisoni F et al (2024) Botulinum toxin injection for chronic anal fissure: a prospective controlled study with long follow-up. Minerva Surg 79:293\u2013302","journal-title":"Minerva Surg"},{"key":"3153_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00384-022-04115-9","volume":"37","author":"DA van Reijn-Baggen","year":"2022","unstructured":"van Reijn-Baggen DA, Dekker L, Elzevier HW, Pelger RCM, Han-Geurts IJM (2022) Management of chronic anal fissure: results of a national survey among gastrointestinal surgeons in the Netherlands. Int J Colorectal Dis 37:973\u2013978","journal-title":"Int J Colorectal Dis"},{"key":"3153_CR13","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s13304-023-01661-x","volume":"75","author":"A Balla","year":"2023","unstructured":"Balla A, Saraceno F, Shalaby M et al (2023) Surgeons\u2019 practice and preferences for the anal fissure treatment: results from an international survey. Updates Surg 75:2279\u20132290","journal-title":"Updates Surg"},{"key":"3153_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/codi.14466","volume":"21","author":"J Siddiqui","year":"2019","unstructured":"Siddiqui J, Fowler GE, Zahid A, Brown K, Young CJ (2019) Treatment of anal fissure: a survey of surgical practice in Australia and New Zealand. Colorectal Dis 21:226\u2013233","journal-title":"Colorectal Dis"},{"key":"3153_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1053\/j.scrs.2010.09.010","volume":"22","author":"DA Etzioni","year":"2011","unstructured":"Etzioni DA (2011) Current management of anal fissure. Semin Colon Rectal Surg 22:2\u20138","journal-title":"Semin Colon Rectal Surg"},{"key":"3153_CR16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1177\/00031348211050830","volume":"89","author":"KA Winter","year":"2023","unstructured":"Winter KA, Savolt T, Quinn KR, Helmer SD, Porter MG, Sanchez NC (2023) Does adding a fissurectomy to botox sphincterotomy increase success rate or just cost? Am Surg 89:961\u2013967","journal-title":"Am Surg"},{"key":"3153_CR17","first-page":"135","volume":"17","author":"K Karabulut","year":"2012","unstructured":"Karabulut K, Aygen E, Kirkil C et al (2012) The impact of fissurectomy combined with botulinum toxin injection in the treatment of chronic anal fissure. Firat Tip Dergisi 17:135\u2013138","journal-title":"Firat Tip Dergisi"},{"key":"3153_CR18","doi-asserted-by":"crossref","DOI":"10.1097\/DCR.0b013e31828d011e","volume":"56","author":"D Nagle","year":"2013","unstructured":"Nagle D, Anez-Bustillos L, Poylin V (2013) Long-term follow-up of botox and botox + fissurectomy for chronic anal fissure. Dis Colon Rectum 56:e144","journal-title":"Dis Colon Rectum"},{"key":"3153_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/gut.44.1.77","volume":"44","author":"C Vaizey","year":"1999","unstructured":"Vaizey C, Carapeti E, Cahill J, Kamm M (1999) Prospective comparison of faecal incontinence grading systems. Gut 44:77\u201380","journal-title":"Gut"},{"key":"3153_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00535-017-1335-0","volume":"52","author":"SM Ebinger","year":"2017","unstructured":"Ebinger SM, Hardt J, Warschkow R et al (2017) Operative and medical treatment of chronic anal fissures-a review and network meta-analysis of randomized controlled trials. J Gastroenterol 52:663\u2013676","journal-title":"J Gastroenterol"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-025-03153-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10151-025-03153-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-025-03153-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T10:01:51Z","timestamp":1766052111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10151-025-03153-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3153"],"URL":"https:\/\/doi.org\/10.1007\/s10151-025-03153-z","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"type":"print","value":"1123-6337"},{"type":"electronic","value":"1128-045X"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests or funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Nepean Blue Mountains Local Health District Human Research Ethics Committee (HREC) on 11th April 2024 in accordance with the National Health and Medical Research Council Act 1992 and the National Statement on Ethical Conduct in Human Research 2023 (ETH00431). A waiver of consent was acquired from the HREC for retrospective data collection. Verbal informed consent was obtained prior to the phone follow-up survey.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical and informed consent"}}],"article-number":"118"}}